（18）18F-氟脱氧葡萄糖PET/MR成像在淋巴瘤中的应用
(18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma.
作者信息
Platzek Ivan
机构信息
Department of Radiology, Dresden University Hospital, Fetscherstr. 74, Dresden 01307, Germany.
出版信息
PET Clin. 2016 Oct;11(4):363-73. doi: 10.1016/j.cpet.2016.05.001. Epub 2016 Jul 30.
PMID:27593243
Abstract
(18)F-Fluorodeoxyglucose (FDG) PET/MR imaging is feasible for initial staging and therapy response assessment in lymphoma. Although FDG PET/MR imaging is equivalent to FDG PET/CT for initial staging of lymphoma, not enough data are available with regard to other indications yet. Diffusion-weighted MR imaging is a promising addition to FDG PET/MR imaging, but has not been evaluated systematically.
摘要
（18）氟代脱氧葡萄糖（FDG）PET/MR成像在淋巴瘤的初始分期和治疗反应评估中是可行的。尽管FDG PET/MR成像在淋巴瘤初始分期方面等同于FDG PET/CT，但关于其他适应证尚无足够数据。扩散加权磁共振成像有望成为FDG PET/MR成像的补充，但尚未进行系统评估。
Zotero 插件